(4S,5R)-2-(1,8-Naphthyridin-2-yl)-4,5-diphenyl-4,5-dihydrooxazole, 97%, 1g

(R)-2-Amino-2-(4-fluoro-3-(trifluoromethyl)phenyl)ethanol hydrochloride, 95%, 1g

(3R)-(+)-3-(tert-Butoxycarbonylamino)pyrrolidine>98.0%(GC)(T)5g

2,6-Dichloropyrazine, 98.0%, 100g

1-(6-BROMO-3,4-DIHYDRO-2(1H)-ISOQUINOLINYL)-2,2,2-TRIFLUORO-ETHANONE, 95.0%, 1g

2-Cyclopropyl-quinoline-4-carboxylic acid, 95.0%, 25g

(4,4-Difluorocyclohexyl)methanamine hydrochloride, 97.0%, 5g

N-(2-ACETYLPHENYL)HEXANAMIDE, 95.0%, 100mg

N-(TERT-BUTYLCARBAMOYL)-5-CYANO-2-((4'-(DIFLUOROMETHOXY)-[1,1'-BIPHENYL]-3-YL)OXY)BENZENESULFONAMIDE, 95%, 50mg

h-Threoninol, 95.0%, 25g

1,2,3,4-Tetrahydroacridin-9-amine hydrochloride, 98.0%, 5g

tert-Butoxydiphenylchlorosilane (stabilized with CaCO3)>95.0%(GC)25mL

(R)-1-Boc-2-chloromethyl-pyrrolidine, 98%, 1g